Profilo
Patrick Malloy is currently the Senior Vice President-Investor Relations at Abivax SA since 2023.
Prior to this, he worked as the VP-Investor Relations & Corporate Communications at Arena Pharmaceuticals, Inc. and as the SVP-Investor Relations & Strategic Communications at VectivBio Holding AG.
Posizioni attive di Patrick Malloy
| Società | Posizione | Inizio |
|---|---|---|
| ABIVAX | Investor Relations Contact | 23/08/2023 |
Precedenti posizioni note di Patrick Malloy
| Società | Posizione | Fine |
|---|---|---|
| VECTIVBIO HOLDING AG | Investor Relations Contact | - |
| ARENA PHARMACEUTICALS | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABIVAX | Health Technology |
| Aziende private | 2 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Patrick Malloy
